Cyclophosphamide Market in Malaysia - Manufacturing and Consumption, Outlook and Forecast 2020-2026
Cyclophosphamide (CP), also known as cytophosphane among other names, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.
This report contains market size and forecasts of Cyclophosphamide in Malaysia, including the following market information:
Malaysia Cyclophosphamide Market Revenue, 2015-2020, 2021-2026, ($ millions)
Malaysia Cyclophosphamide Market Consumption, 2015-2020, 2021-2026, (Person)
Malaysia Cyclophosphamide Production Capacity, 2015-2020, 2021-2026, (Person)
Top Five Competitors in Malaysia Cyclophosphamide Market 2019 (%)
The global Cyclophosphamide market was valued at 648.4 million in 2019 and is projected to reach US$ 702.9 million by 2026, at a CAGR of 2.0% during the forecast period. While the Cyclophosphamide market size in Malaysia was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cyclophosphamide manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Cyclophosphamide production and consumption in Malaysia
Total Market by Segment:
Malaysia Cyclophosphamide Market, By Type, 2015-2020, 2021-2026 ($ millions) & (Person)
Malaysia Cyclophosphamide Market Segment Percentages, By Type, 2019 (%)
Malaysia Cyclophosphamide Market Segment Percentages, By Application, 2019 (%)
The report also provides analysis of leading market participants including:
Total Cyclophosphamide Market Competitors Revenues in Malaysia, by Players 2015-2020 (Estimated), ($ millions)
Total Cyclophosphamide Market Competitors Revenues Share in Malaysia, by Players 2019 (%)
Total Malaysia Cyclophosphamide Market Competitors Sales, by Players 2015-2020 (Estimated), (Person)
Total Malaysia Cyclophosphamide Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
This report contains market size and forecasts of Cyclophosphamide in Malaysia, including the following market information:
Malaysia Cyclophosphamide Market Revenue, 2015-2020, 2021-2026, ($ millions)
Malaysia Cyclophosphamide Market Consumption, 2015-2020, 2021-2026, (Person)
Malaysia Cyclophosphamide Production Capacity, 2015-2020, 2021-2026, (Person)
Top Five Competitors in Malaysia Cyclophosphamide Market 2019 (%)
The global Cyclophosphamide market was valued at 648.4 million in 2019 and is projected to reach US$ 702.9 million by 2026, at a CAGR of 2.0% during the forecast period. While the Cyclophosphamide market size in Malaysia was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cyclophosphamide manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Cyclophosphamide production and consumption in Malaysia
Total Market by Segment:
Malaysia Cyclophosphamide Market, By Type, 2015-2020, 2021-2026 ($ millions) & (Person)
Malaysia Cyclophosphamide Market Segment Percentages, By Type, 2019 (%)
- High-Dose
- Low-Dose
Malaysia Cyclophosphamide Market Segment Percentages, By Application, 2019 (%)
- Cancer
- Autoimmune Diseases
- AL Amyloidosis
- Others
The report also provides analysis of leading market participants including:
Total Cyclophosphamide Market Competitors Revenues in Malaysia, by Players 2015-2020 (Estimated), ($ millions)
Total Cyclophosphamide Market Competitors Revenues Share in Malaysia, by Players 2019 (%)
Total Malaysia Cyclophosphamide Market Competitors Sales, by Players 2015-2020 (Estimated), (Person)
Total Malaysia Cyclophosphamide Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
- Baxter
- Novartis
- Hikma Pharmaceuticals
- Amneal Pharmaceuticals LLC
- Jiangsu Hengrui Medicine
- NorthStar Rx LLC
- GLS Pharma
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Cyclophosphamide Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Malaysia Cyclophosphamide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: MALAYSIA CYCLOPHOSPHAMIDE OVERALL MARKET SIZE
2.1 Malaysia Cyclophosphamide Market Size: 2020 VS 2026
2.2 Malaysia Cyclophosphamide Revenue, Prospects & Forecasts: 2015-2026
2.3 Malaysia Cyclophosphamide Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Cyclophosphamide Players in Malaysia (including Foreign and Local Companies)
3.2 Top Malaysia Cyclophosphamide Companies Ranked by Revenue
3.3 Malaysia Cyclophosphamide Revenue by Companies (including Foreign and Local Companies)
3.4 Malaysia Cyclophosphamide Sales by Companies (including Foreign and Local Companies)
3.5 Malaysia Cyclophosphamide Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Cyclophosphamide Companies in Malaysia, by Revenue in 2019
3.7 Malaysia Manufacturers Cyclophosphamide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cyclophosphamide Players in Malaysia
3.8.1 List of Malaysia Tier 1 Cyclophosphamide Companies
3.8.2 List of Malaysia Tier 2 and Tier 3 Cyclophosphamide Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Malaysia Cyclophosphamide Market Size Markets, 2020 & 2026
4.1.2 High-Dose
4.1.3 Low-Dose
4.2 By Type - Malaysia Cyclophosphamide Revenue & Forecasts
4.2.1 By Type - Malaysia Cyclophosphamide Revenue, 2015-2020
4.2.2 By Type - Malaysia Cyclophosphamide Revenue, 2021-2026
4.2.3 By Type - Malaysia Cyclophosphamide Revenue Market Share, 2015-2026
4.3 By Type - Malaysia Cyclophosphamide Sales & Forecasts
4.3.1 By Type - Malaysia Cyclophosphamide Sales, 2015-2020
4.3.2 By Type - Malaysia Cyclophosphamide Sales, 2021-2026
4.3.3 By Type - Malaysia Cyclophosphamide Sales Market Share, 2015-2026
4.4 By Type - Malaysia Cyclophosphamide Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Malaysia Cyclophosphamide Market Size, 2020 & 2026
5.1.2 Cancer
5.1.3 Autoimmune Diseases
5.1.4 AL Amyloidosis
5.1.5 Others
5.2 By Application - Malaysia Cyclophosphamide Revenue & Forecasts
5.2.1 By Application - Malaysia Cyclophosphamide Revenue, 2015-2020
5.2.2 By Application - Malaysia Cyclophosphamide Revenue, 2021-2026
5.2.3 By Application - Malaysia Cyclophosphamide Revenue Market Share, 2015-2026
5.3 By Application - Malaysia Cyclophosphamide Sales & Forecasts
5.3.1 By Application - Malaysia Cyclophosphamide Sales, 2015-2020
5.3.2 By Application - Malaysia Cyclophosphamide Sales, 2021-2026
5.3.3 By Application - Malaysia Cyclophosphamide Sales Market Share, 2015-2026
5.4 By Application - Malaysia Cyclophosphamide Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 Baxter
6.1.1 Baxter Corporate Summary
6.1.2 Baxter Business Overview
6.1.3 Baxter Cyclophosphamide Major Product Offerings
6.1.4 Baxter Sales and Revenue in Malaysia (2015-2020)
6.1.5 Baxter Key News
6.2 Novartis
6.2.1 Novartis Corporate Summary
6.2.2 Novartis Business Overview
6.2.3 Novartis Cyclophosphamide Major Product Offerings
6.2.4 Novartis Sales and Revenue in Malaysia (2015-2020)
6.2.5 Novartis Key News
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Corporate Summary
6.3.2 Hikma Pharmaceuticals Business Overview
6.3.3 Hikma Pharmaceuticals Cyclophosphamide Major Product Offerings
6.3.4 Hikma Pharmaceuticals Sales and Revenue in Malaysia (2015-2020)
6.3.5 Hikma Pharmaceuticals Key News
6.4 Amneal Pharmaceuticals LLC
6.4.1 Amneal Pharmaceuticals LLC Corporate Summary
6.4.2 Amneal Pharmaceuticals LLC Business Overview
6.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Major Product Offerings
6.4.4 Amneal Pharmaceuticals LLC Sales and Revenue in Malaysia (2015-2020)
6.4.5 Amneal Pharmaceuticals LLC Key News
6.5 Jiangsu Hengrui Medicine
6.5.1 Jiangsu Hengrui Medicine Corporate Summary
6.5.2 Jiangsu Hengrui Medicine Business Overview
6.5.3 Jiangsu Hengrui Medicine Cyclophosphamide Major Product Offerings
6.5.4 Jiangsu Hengrui Medicine Sales and Revenue in Malaysia (2015-2020)
6.5.5 Jiangsu Hengrui Medicine Key News
6.6 NorthStar Rx LLC
6.6.1 NorthStar Rx LLC Corporate Summary
6.6.2 NorthStar Rx LLC Business Overview
6.6.3 NorthStar Rx LLC Cyclophosphamide Major Product Offerings
6.6.4 NorthStar Rx LLC Sales and Revenue in Malaysia (2015-2020)
6.6.5 NorthStar Rx LLC Key News
6.7 GLS Pharma
6.6.1 GLS Pharma Corporate Summary
6.6.2 GLS Pharma Business Overview
6.6.3 GLS Pharma Cyclophosphamide Major Product Offerings
6.4.4 GLS Pharma Sales and Revenue in Malaysia (2015-2020)
6.7.5 GLS Pharma Key News
6.8 CSC Pharmaceuticals International
6.8.1 CSC Pharmaceuticals International Corporate Summary
6.8.2 CSC Pharmaceuticals International Business Overview
6.8.3 CSC Pharmaceuticals International Cyclophosphamide Major Product Offerings
6.8.4 CSC Pharmaceuticals International Sales and Revenue in Malaysia (2015-2020)
6.8.5 CSC Pharmaceuticals International Key News
7 CYCLOPHOSPHAMIDE PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Cyclophosphamide Production Capacity and Value in Malaysia, Situation Analysis and Prediction, 2015-2026
7.1.1 Malaysia Cyclophosphamide Production Capacity, 2015-2026
7.1.2 Malaysia Cyclophosphamide Production 2015-2026
7.1.3 Malaysia Cyclophosphamide Production Value 2015-2026
7.2 Key Local Cyclophosphamide Manufacturers in Malaysia
7.2.1 Malaysia Key Local Cyclophosphamide Manufacturers Production Capacity
7.2.2 Malaysia Key Local Cyclophosphamide Manufacturers Production
7.2.3 Malaysia Key Local Cyclophosphamide Manufacturers Production Value
7.2.4 The Proportion of Cyclophosphamide Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
7.3 Cyclophosphamide Export and Import in Malaysia
7.3.1 Malaysia Cyclophosphamide Export Market
7.3.2 Malaysia Cyclophosphamide Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for Malaysia Cyclophosphamide Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON CYCLOPHOSPHAMIDE SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Cyclophosphamide Distributors and Sales Agents in Malaysia
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
1.1 Cyclophosphamide Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Malaysia Cyclophosphamide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: MALAYSIA CYCLOPHOSPHAMIDE OVERALL MARKET SIZE
2.1 Malaysia Cyclophosphamide Market Size: 2020 VS 2026
2.2 Malaysia Cyclophosphamide Revenue, Prospects & Forecasts: 2015-2026
2.3 Malaysia Cyclophosphamide Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Cyclophosphamide Players in Malaysia (including Foreign and Local Companies)
3.2 Top Malaysia Cyclophosphamide Companies Ranked by Revenue
3.3 Malaysia Cyclophosphamide Revenue by Companies (including Foreign and Local Companies)
3.4 Malaysia Cyclophosphamide Sales by Companies (including Foreign and Local Companies)
3.5 Malaysia Cyclophosphamide Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Cyclophosphamide Companies in Malaysia, by Revenue in 2019
3.7 Malaysia Manufacturers Cyclophosphamide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cyclophosphamide Players in Malaysia
3.8.1 List of Malaysia Tier 1 Cyclophosphamide Companies
3.8.2 List of Malaysia Tier 2 and Tier 3 Cyclophosphamide Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Malaysia Cyclophosphamide Market Size Markets, 2020 & 2026
4.1.2 High-Dose
4.1.3 Low-Dose
4.2 By Type - Malaysia Cyclophosphamide Revenue & Forecasts
4.2.1 By Type - Malaysia Cyclophosphamide Revenue, 2015-2020
4.2.2 By Type - Malaysia Cyclophosphamide Revenue, 2021-2026
4.2.3 By Type - Malaysia Cyclophosphamide Revenue Market Share, 2015-2026
4.3 By Type - Malaysia Cyclophosphamide Sales & Forecasts
4.3.1 By Type - Malaysia Cyclophosphamide Sales, 2015-2020
4.3.2 By Type - Malaysia Cyclophosphamide Sales, 2021-2026
4.3.3 By Type - Malaysia Cyclophosphamide Sales Market Share, 2015-2026
4.4 By Type - Malaysia Cyclophosphamide Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Malaysia Cyclophosphamide Market Size, 2020 & 2026
5.1.2 Cancer
5.1.3 Autoimmune Diseases
5.1.4 AL Amyloidosis
5.1.5 Others
5.2 By Application - Malaysia Cyclophosphamide Revenue & Forecasts
5.2.1 By Application - Malaysia Cyclophosphamide Revenue, 2015-2020
5.2.2 By Application - Malaysia Cyclophosphamide Revenue, 2021-2026
5.2.3 By Application - Malaysia Cyclophosphamide Revenue Market Share, 2015-2026
5.3 By Application - Malaysia Cyclophosphamide Sales & Forecasts
5.3.1 By Application - Malaysia Cyclophosphamide Sales, 2015-2020
5.3.2 By Application - Malaysia Cyclophosphamide Sales, 2021-2026
5.3.3 By Application - Malaysia Cyclophosphamide Sales Market Share, 2015-2026
5.4 By Application - Malaysia Cyclophosphamide Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 Baxter
6.1.1 Baxter Corporate Summary
6.1.2 Baxter Business Overview
6.1.3 Baxter Cyclophosphamide Major Product Offerings
6.1.4 Baxter Sales and Revenue in Malaysia (2015-2020)
6.1.5 Baxter Key News
6.2 Novartis
6.2.1 Novartis Corporate Summary
6.2.2 Novartis Business Overview
6.2.3 Novartis Cyclophosphamide Major Product Offerings
6.2.4 Novartis Sales and Revenue in Malaysia (2015-2020)
6.2.5 Novartis Key News
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Corporate Summary
6.3.2 Hikma Pharmaceuticals Business Overview
6.3.3 Hikma Pharmaceuticals Cyclophosphamide Major Product Offerings
6.3.4 Hikma Pharmaceuticals Sales and Revenue in Malaysia (2015-2020)
6.3.5 Hikma Pharmaceuticals Key News
6.4 Amneal Pharmaceuticals LLC
6.4.1 Amneal Pharmaceuticals LLC Corporate Summary
6.4.2 Amneal Pharmaceuticals LLC Business Overview
6.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Major Product Offerings
6.4.4 Amneal Pharmaceuticals LLC Sales and Revenue in Malaysia (2015-2020)
6.4.5 Amneal Pharmaceuticals LLC Key News
6.5 Jiangsu Hengrui Medicine
6.5.1 Jiangsu Hengrui Medicine Corporate Summary
6.5.2 Jiangsu Hengrui Medicine Business Overview
6.5.3 Jiangsu Hengrui Medicine Cyclophosphamide Major Product Offerings
6.5.4 Jiangsu Hengrui Medicine Sales and Revenue in Malaysia (2015-2020)
6.5.5 Jiangsu Hengrui Medicine Key News
6.6 NorthStar Rx LLC
6.6.1 NorthStar Rx LLC Corporate Summary
6.6.2 NorthStar Rx LLC Business Overview
6.6.3 NorthStar Rx LLC Cyclophosphamide Major Product Offerings
6.6.4 NorthStar Rx LLC Sales and Revenue in Malaysia (2015-2020)
6.6.5 NorthStar Rx LLC Key News
6.7 GLS Pharma
6.6.1 GLS Pharma Corporate Summary
6.6.2 GLS Pharma Business Overview
6.6.3 GLS Pharma Cyclophosphamide Major Product Offerings
6.4.4 GLS Pharma Sales and Revenue in Malaysia (2015-2020)
6.7.5 GLS Pharma Key News
6.8 CSC Pharmaceuticals International
6.8.1 CSC Pharmaceuticals International Corporate Summary
6.8.2 CSC Pharmaceuticals International Business Overview
6.8.3 CSC Pharmaceuticals International Cyclophosphamide Major Product Offerings
6.8.4 CSC Pharmaceuticals International Sales and Revenue in Malaysia (2015-2020)
6.8.5 CSC Pharmaceuticals International Key News
7 CYCLOPHOSPHAMIDE PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Cyclophosphamide Production Capacity and Value in Malaysia, Situation Analysis and Prediction, 2015-2026
7.1.1 Malaysia Cyclophosphamide Production Capacity, 2015-2026
7.1.2 Malaysia Cyclophosphamide Production 2015-2026
7.1.3 Malaysia Cyclophosphamide Production Value 2015-2026
7.2 Key Local Cyclophosphamide Manufacturers in Malaysia
7.2.1 Malaysia Key Local Cyclophosphamide Manufacturers Production Capacity
7.2.2 Malaysia Key Local Cyclophosphamide Manufacturers Production
7.2.3 Malaysia Key Local Cyclophosphamide Manufacturers Production Value
7.2.4 The Proportion of Cyclophosphamide Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
7.3 Cyclophosphamide Export and Import in Malaysia
7.3.1 Malaysia Cyclophosphamide Export Market
7.3.2 Malaysia Cyclophosphamide Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for Malaysia Cyclophosphamide Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON CYCLOPHOSPHAMIDE SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Cyclophosphamide Distributors and Sales Agents in Malaysia
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Cyclophosphamide in Malaysia
Table 2. Top Players in Malaysia, Ranking by Revenue (2019)
Table 3. Malaysia Cyclophosphamide Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Malaysia Cyclophosphamide Revenue Share by Companies, 2015-2020
Table 5. Malaysia Cyclophosphamide Sales by Companies, (Person), 2015-2020
Table 6. Malaysia Cyclophosphamide Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Cyclophosphamide Price (2015-2020) (Average Cost/Person)
Table 8. Malaysia Manufacturers Cyclophosphamide Product Type
Table 9. List of Malaysia Tier 1 Cyclophosphamide Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Malaysia Tier 2 and Tier 3 Cyclophosphamide Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Cyclophosphamide Revenue in Malaysia (US$, Mn), 2015-2020
Table 12. By Type - Cyclophosphamide Revenue in Malaysia (US$, Mn), 2021-2026
Table 13. By Type - Cyclophosphamide Sales in Malaysia (Person), 2015-2020
Table 14. By Type - Cyclophosphamide Sales in Malaysia (Person), 2021-2026
Table 15. By Application - Cyclophosphamide Revenue in Malaysia, (US$, Mn), 2015-2020
Table 16. By Application - Cyclophosphamide Revenue in Malaysia, (US$, Mn), 2021-2026
Table 17. By Application - Cyclophosphamide Sales in Malaysia, (Person), 2015-2020
Table 18. By Application - Cyclophosphamide Sales in Malaysia, (Person), 2021-2026
Table 19. Baxter Corporate Summary
Table 20. Baxter Cyclophosphamide Product Offerings
Table 21. Baxter Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 22. Novartis Corporate Summary
Table 23. Novartis Cyclophosphamide Product Offerings
Table 24. Novartis Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 25. Hikma Pharmaceuticals Corporate Summary
Table 26. Hikma Pharmaceuticals Cyclophosphamide Product Offerings
Table 27. Hikma Pharmaceuticals Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 28. Amneal Pharmaceuticals LLC Corporate Summary
Table 29. Amneal Pharmaceuticals LLC Cyclophosphamide Product Offerings
Table 30. Amneal Pharmaceuticals LLC Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 31. Jiangsu Hengrui Medicine Corporate Summary
Table 32. Jiangsu Hengrui Medicine Cyclophosphamide Product Offerings
Table 33. Jiangsu Hengrui Medicine Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 34. NorthStar Rx LLC Corporate Summary
Table 35. NorthStar Rx LLC Cyclophosphamide Product Offerings
Table 36. NorthStar Rx LLC Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 37. GLS Pharma Corporate Summary
Table 38. GLS Pharma Cyclophosphamide Product Offerings
Table 39. GLS Pharma Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 40. CSC Pharmaceuticals International Corporate Summary
Table 41. CSC Pharmaceuticals International Cyclophosphamide Product Offerings
Table 42. CSC Pharmaceuticals International Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 43. Cyclophosphamide Production Capacity (Person) of Local Manufacturers in Malaysia, 2015-2020
Table 44. Cyclophosphamide Production (Person) of Local Manufacturers in Malaysia, 2015-2020
Table 45. Malaysia Cyclophosphamide Production Market Share of Local Manufacturers, 2015-2020
Table 46. Cyclophosphamide Production Value (US$, Mn) of Local Manufacturers in Malaysia, 2015-2020
Table 47. Malaysia Cyclophosphamide Production Value Market Share of Local Manufacturers, 2015-2020
Table 48. The Percentage of Cyclophosphamide Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
Table 49. The Percentage of Cyclophosphamide Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
Table 50. Dangeguojia Cyclophosphamide Sales (Consumption), Production, Export and Import, 2015-2020
Table 51. Raw Materials and Suppliers
Table 52. Cyclophosphamide Downstream Clients in Malaysia
Table 53. Cyclophosphamide Distributors and Sales Agents in Malaysia
Table 1. Key Players of Cyclophosphamide in Malaysia
Table 2. Top Players in Malaysia, Ranking by Revenue (2019)
Table 3. Malaysia Cyclophosphamide Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Malaysia Cyclophosphamide Revenue Share by Companies, 2015-2020
Table 5. Malaysia Cyclophosphamide Sales by Companies, (Person), 2015-2020
Table 6. Malaysia Cyclophosphamide Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Cyclophosphamide Price (2015-2020) (Average Cost/Person)
Table 8. Malaysia Manufacturers Cyclophosphamide Product Type
Table 9. List of Malaysia Tier 1 Cyclophosphamide Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Malaysia Tier 2 and Tier 3 Cyclophosphamide Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Cyclophosphamide Revenue in Malaysia (US$, Mn), 2015-2020
Table 12. By Type - Cyclophosphamide Revenue in Malaysia (US$, Mn), 2021-2026
Table 13. By Type - Cyclophosphamide Sales in Malaysia (Person), 2015-2020
Table 14. By Type - Cyclophosphamide Sales in Malaysia (Person), 2021-2026
Table 15. By Application - Cyclophosphamide Revenue in Malaysia, (US$, Mn), 2015-2020
Table 16. By Application - Cyclophosphamide Revenue in Malaysia, (US$, Mn), 2021-2026
Table 17. By Application - Cyclophosphamide Sales in Malaysia, (Person), 2015-2020
Table 18. By Application - Cyclophosphamide Sales in Malaysia, (Person), 2021-2026
Table 19. Baxter Corporate Summary
Table 20. Baxter Cyclophosphamide Product Offerings
Table 21. Baxter Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 22. Novartis Corporate Summary
Table 23. Novartis Cyclophosphamide Product Offerings
Table 24. Novartis Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 25. Hikma Pharmaceuticals Corporate Summary
Table 26. Hikma Pharmaceuticals Cyclophosphamide Product Offerings
Table 27. Hikma Pharmaceuticals Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 28. Amneal Pharmaceuticals LLC Corporate Summary
Table 29. Amneal Pharmaceuticals LLC Cyclophosphamide Product Offerings
Table 30. Amneal Pharmaceuticals LLC Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 31. Jiangsu Hengrui Medicine Corporate Summary
Table 32. Jiangsu Hengrui Medicine Cyclophosphamide Product Offerings
Table 33. Jiangsu Hengrui Medicine Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 34. NorthStar Rx LLC Corporate Summary
Table 35. NorthStar Rx LLC Cyclophosphamide Product Offerings
Table 36. NorthStar Rx LLC Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 37. GLS Pharma Corporate Summary
Table 38. GLS Pharma Cyclophosphamide Product Offerings
Table 39. GLS Pharma Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 40. CSC Pharmaceuticals International Corporate Summary
Table 41. CSC Pharmaceuticals International Cyclophosphamide Product Offerings
Table 42. CSC Pharmaceuticals International Cyclophosphamide Sales (Person), Revenue (US$, Mn) and Average Price (Average Cost/Person) (2015-2020)
Table 43. Cyclophosphamide Production Capacity (Person) of Local Manufacturers in Malaysia, 2015-2020
Table 44. Cyclophosphamide Production (Person) of Local Manufacturers in Malaysia, 2015-2020
Table 45. Malaysia Cyclophosphamide Production Market Share of Local Manufacturers, 2015-2020
Table 46. Cyclophosphamide Production Value (US$, Mn) of Local Manufacturers in Malaysia, 2015-2020
Table 47. Malaysia Cyclophosphamide Production Value Market Share of Local Manufacturers, 2015-2020
Table 48. The Percentage of Cyclophosphamide Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
Table 49. The Percentage of Cyclophosphamide Production Sold in Malaysia and Sold Other Than Malaysia by Manufacturers
Table 50. Dangeguojia Cyclophosphamide Sales (Consumption), Production, Export and Import, 2015-2020
Table 51. Raw Materials and Suppliers
Table 52. Cyclophosphamide Downstream Clients in Malaysia
Table 53. Cyclophosphamide Distributors and Sales Agents in Malaysia
LIST OF FIGURES
Figure 1. Cyclophosphamide Segment by Type
Figure 2. Cyclophosphamide Segment by Application
Figure 3. Dangeguojia Cyclophosphamide Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Cyclophosphamide Market Size in Malaysia, (US$, Mn) & (Person): 2020 VS 2026
Figure 6. Malaysia Cyclophosphamide Revenue, 2015-2026 (US$, Mn)
Figure 7. Cyclophosphamide Sales in Malaysia: 2015-2026 (Person)
Figure 8. The Top 3 and 5 Players Market Share by Cyclophosphamide Revenue in 2019
Figure 9. By Type - Malaysia Cyclophosphamide Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Malaysia Cyclophosphamide Market Share, 2015-2020
Figure 11. By Type - Malaysia Cyclophosphamide Market Share, 2020-2026
Figure 12. By Type - Malaysia Cyclophosphamide Price (Average Cost/Person), 2015-2026
Figure 13. By Application - Cyclophosphamide Revenue in Malaysia (US$, Mn), 2020 & 2026
Figure 14. By Application - Malaysia Cyclophosphamide Market Share, 2015-2020
Figure 15. By Application - Malaysia Cyclophosphamide Market Share, 2020-2026
Figure 16. By Application -Malaysia Cyclophosphamide Price (Average Cost/Person), 2015-2026
Figure 17. Malaysia Cyclophosphamide Production Capacity (Person), 2015-2026
Figure 18. Malaysia Cyclophosphamide Actual Output (Person), 2015-2026
Figure 19. Malaysia Cyclophosphamide Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Malaysia Cyclophosphamide Export Destination, 2019
Figure 21. The Source of Imports of Malaysia Cyclophosphamide, 2019
Figure 22. PEST Analysis for Malaysia Cyclophosphamide Market in 2020
Figure 23. Cyclophosphamide Market Opportunities & Trends in Malaysia
Figure 24. Cyclophosphamide Market Drivers in Malaysia
Figure 25. Cyclophosphamide Market Restraints in Malaysia
Figure 26. Cyclophosphamide Industry Value Chain
Figure 1. Cyclophosphamide Segment by Type
Figure 2. Cyclophosphamide Segment by Application
Figure 3. Dangeguojia Cyclophosphamide Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Cyclophosphamide Market Size in Malaysia, (US$, Mn) & (Person): 2020 VS 2026
Figure 6. Malaysia Cyclophosphamide Revenue, 2015-2026 (US$, Mn)
Figure 7. Cyclophosphamide Sales in Malaysia: 2015-2026 (Person)
Figure 8. The Top 3 and 5 Players Market Share by Cyclophosphamide Revenue in 2019
Figure 9. By Type - Malaysia Cyclophosphamide Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Malaysia Cyclophosphamide Market Share, 2015-2020
Figure 11. By Type - Malaysia Cyclophosphamide Market Share, 2020-2026
Figure 12. By Type - Malaysia Cyclophosphamide Price (Average Cost/Person), 2015-2026
Figure 13. By Application - Cyclophosphamide Revenue in Malaysia (US$, Mn), 2020 & 2026
Figure 14. By Application - Malaysia Cyclophosphamide Market Share, 2015-2020
Figure 15. By Application - Malaysia Cyclophosphamide Market Share, 2020-2026
Figure 16. By Application -Malaysia Cyclophosphamide Price (Average Cost/Person), 2015-2026
Figure 17. Malaysia Cyclophosphamide Production Capacity (Person), 2015-2026
Figure 18. Malaysia Cyclophosphamide Actual Output (Person), 2015-2026
Figure 19. Malaysia Cyclophosphamide Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Malaysia Cyclophosphamide Export Destination, 2019
Figure 21. The Source of Imports of Malaysia Cyclophosphamide, 2019
Figure 22. PEST Analysis for Malaysia Cyclophosphamide Market in 2020
Figure 23. Cyclophosphamide Market Opportunities & Trends in Malaysia
Figure 24. Cyclophosphamide Market Drivers in Malaysia
Figure 25. Cyclophosphamide Market Restraints in Malaysia
Figure 26. Cyclophosphamide Industry Value Chain
